Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases

Antimicrob Agents Chemother. 1992 Nov;36(11):2536-8. doi: 10.1128/AAC.36.11.2536.

Abstract

The aminoglycoside-modifying enzymes present in the first 120 clinical isolates harboring extended-spectrum beta-lactamases isolated in Spain were studied. Most of these isolates (84%) were gentamicin resistant. The enzymes most frequently associated and cotransferred with SHV-2 or TEM-type beta-lactamases were AAC(3)V, APH(3"), and APH(3')I.

MeSH terms

  • Aminoglycosides
  • Anti-Bacterial Agents / metabolism*
  • Drug Resistance, Microbial / physiology
  • Enterobacteriaceae / enzymology*
  • Humans
  • Microbial Sensitivity Tests
  • beta-Lactamases / biosynthesis*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • beta-Lactamases